Noncoding RNAs: Key molecules in understanding and treating pain

Trends in Molecular Medicine

Volumn 20, Issue 8, 2014, Pages 437-448

  Bali, Kiran Kumar ^a,b   Kuner, Rohini ^a,b  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b EUROPEAN MOLECULAR BIOLOGY LABORATORY   (Germany)

Author keywords

Chronic pain; LncRNA; MiRNA; NcRNA; Pain mechanisms

Indexed keywords

UNTRANSLATED RNA;

ANALGESIA; ANIMAL; BRAIN; GENE EXPRESSION REGULATION; GENETICS; HUMAN; METABOLISM; PAIN; PATHOLOGY; PROCEDURES; SPINAL CORD;

ANIMALS; BRAIN; GENE EXPRESSION REGULATION; HUMANS; PAIN; PAIN MANAGEMENT; RNA, UNTRANSLATED; SPINAL CORD;

EID: 84905092201     PISSN: 14714914     EISSN: 1471499X     Source Type: Journal    
DOI: 10.1016/j.molmed.2014.05.006     Document Type: Review

References (109)

1. Aboobaker A.A., et al. Drosophila microRNAs exhibit diverse spatial expression patterns during embryonic development. Proc. Natl. Acad. Sci. U.S.A. 2005, 102:18017-18022.
2. Hengst U., et al. Functional and selective RNA interference in developing axons and growth cones. J. Neurosci. 2006, 26:5727-5732.
3. Johnston R.J., et al. MicroRNAs acting in a double-negative feedback loop to control a neuronal cell fate decision. Proc. Natl. Acad. Sci. U.S.A. 2005, 102:12449-12454.
4. Schratt G.M., et al. A brain-specific microRNA regulates dendritic spine development. Nature 2006, 439:283-289.
5. Zhiguo Wang B.Y. MicroRNA Expression Detection Methods 2010, Springer.
6. Murray D.W. An overview of microRNA methods: expression profiling and target identification. Molecular Profiling: Methods and Protocols, Methods in Molecular Biology 2012, 119-138. Springer. V. Espina (Ed.).
7. Kynast K.L., et al. Novel findings in pain processing pathways: implications for miRNAs as future therapeutic targets. Exp. Rev. Neurother. 2013, 13:515-525.
8. Niederberger E., et al. MicroRNAs as new players in the pain game. Pain 2011, 152:1455-1458.
9. Bali K.K., et al. Genome-wide identification and functional analyses of microRNA signatures associated with cancer pain. EMBO Mol. Med. 2013, 5:1740-1758.
10. Aldrich B.T., et al. Changes in expression of sensory organ-specific microRNAs in rat dorsal root ganglia in association with mechanical hypersensitivity induced by spinal nerve ligation. Neuroscience 2009, 164:711-723.
11. Kloosterman W.P., et al. In situ detection of miRNAs in animal embryos using LNA-modified oligonucleotide probes. Nat. Methods 2006, 3:27-29.
12. Weston M.D., et al. MicroRNA gene expression in the mouse inner ear. Brain Res. 2006, 1111:95-104.
13. Xu S., et al. MicroRNA (miRNA) transcriptome of mouse retina and identification of a sensory organ-specific miRNA cluster. J. Biol. Chem. 2007, 282:25053-25066.
14. Wienholds E., Plasterk R.H. MicroRNA function in animal development. FEBS Lett. 2005, 579:5911-5922.
15. Lin C.R., et al. Intrathecal miR-183 delivery suppresses mechanical allodynia in mononeuropathic rats. Eur. J. Neurosci. 2014, 39:1682-1689.
16. Tam Tam S., et al. MicroRNA-143 expression in dorsal root ganglion neurons. Cell Tissue Res. 2011, 346:163-173.
17. von Schack D., et al. Dynamic changes in the microRNA expression profile reveal multiple regulatory mechanisms in the spinal nerve ligation model of neuropathic pain. PLoS ONE 2011, 6:e17670.
18. Kusuda R., et al. Differential expression of microRNAs in mouse pain models. Mol. Pain 2011, 7:17.
19. John A., et al. Bcl11a is required for neuronal morphogenesis and sensory circuit formation in dorsal spinal cord development. Development 2012, 139:1831-1841.
20. Sun H., et al. Dorsal horn-enriched genes identified by DNA microarray, in situ hybridization and immunohistochemistry. BMC Neurosci. 2002, 3:11.
21. Bar K.J., et al. Increased prefrontal activation during pain perception in major depression. Biol. Psychiatry 2007, 62:1281-1287.
22. Wiech K., et al. Anterolateral prefrontal cortex mediates the analgesic effect of expected and perceived control over pain. J. Neurosci. 2006, 26:11501-11509.
23. Poh K.W., et al. MicroRNA changes in the mouse prefrontal cortex after inflammatory pain. Eur. J. Pain 2011, 15. 801.el-801.e12.
24. Imai S., et al. Change in microRNAs associated with neuronal adaptive responses in the nucleus accumbens under neuropathic pain. J. Neurosci. 2011, 31:15294-15299.
25. Davis S., et al. Improved targeting of miRNA with antisense oligonucleotides. Nucleic Acids Res. 2006, 34:2294-2304.
26. Kloosterman W.P., et al. Targeted inhibition of miRNA maturation with morpholinos reveals a role for miR-375 in pancreatic islet development. PLoS Biol. 2007, 5:e203.
27. Obad S., et al. Silencing of microRNA families by seed-targeting tiny LNAs. Nat. Genet. 2011, 43:371-378.
28. Elmen J., et al. LNA-mediated microRNA silencing in non-human primates. Nature 2008, 452:896-899.
29. Krutzfeldt J., et al. Silencing of microRNAs in vivo with 'antagomirs'. Nature 2005, 438:685-689.
30. Cheng H.Y., et al. MicroRNA modulation of circadian-clock period and entrainment. Neuron 2007, 54:813-829.
31. Park C.Y., et al. Analysis of microRNA knockouts in mice. Hum. Mol. Genet. 2010, 19:R169-R175.
32. Zhao J., et al. Small RNAs control sodium channel expression, nociceptor excitability, and pain thresholds. J. Neurosci. 2010, 30:10860-10871.
33. Prosser H.M., et al. A resource of vectors and ES cells for targeted deletion of microRNAs in mice. Nat. Biotechnol. 2011, 29:840-845.
34. Favereaux A., et al. Bidirectional integrative regulation of Cav1.2 calcium channel by microRNA miR-103: role in pain. EMBO J. 2011, 30:3830-3841.
35. Kynast K.L., et al. Modulation of central nervous system-specific microRNA-124a alters the inflammatory response in the formalin test in mice. Pain 2013, 154:368-376.
36. Crew E., et al. MicroRNA conjugated gold nanoparticles and cell transfection. Anal. Chem. 2012, 84:26-29.
37. Ghosh R., et al. A gold nanoparticle platform for the delivery of functional microRNAs into cancer cells. Biomaterials 2013, 34:807-816.
38. Hao L., et al. Nucleic acid-gold nanoparticle conjugates as mimics of microRNA. Small 2011, 7:3158-3162.
39. Li J., et al. Biodegradable calcium phosphate nanoparticle with lipid coating for systemic siRNA delivery. J. Control. Release 2010, 142:416-421.
40. Pramanik D., et al. Restitution of tumor suppressor microRNAs using a systemic nanovector inhibits pancreatic cancer growth in mice. Mol. Cancer Ther. 2011, 10:1470-1480.
41. Trang P., et al. Systemic delivery of tumor suppressor microRNA mimics using a neutral lipid emulsion inhibits lung tumors in mice. Mol. Ther. 2011, 19:1116-1122.
42. Chen Y., et al. Nanoparticles modified with tumor-targeting scFv deliver siRNA and miRNA for cancer therapy. Mol. Ther. 2010, 18:1650-1656.
43. Hwang do W., et al. A brain-targeted rabies virus glycoprotein-disulfide linked PEI nanocarrier for delivery of neurogenic microRNA. Biomaterials 2011, 32:4968-4975.
44. Ebert M.S., et al. MicroRNA sponges: competitive inhibitors of small RNAs in mammalian cells. Nat. Methods 2007, 4:721-726.
45. Care A., et al. MicroRNA-133 controls cardiac hypertrophy. Nat. Med. 2007, 13:613-618.
46. Du Y., et al. Down-regulation of miR-141 in gastric cancer and its involvement in cell growth. J. Gastroenterol. 2009, 44:556-561.
47. Krol J., et al. The widespread regulation of microRNA biogenesis, function and decay. Nat. Rev. Genet. 2010, 11:597-610.
48. Tappe A., et al. Synaptic scaffolding protein Homer1a protects against chronic inflammatory pain. Nat. Med. 2006, 12:677-681.
49. Terashima T., et al. DRG-targeted helper-dependent adenoviruses mediate selective gene delivery for therapeutic rescue of sensory neuronopathies in mice. J. Clin. Invest. 2009, 119:2100-2112.
50. Dweep H., et al. In-silico algorithms for the screening of possible microRNA binding sites and their interactions. Curr. Genomics 2013, 14:127-136.
51. Zheng H., et al. Advances in the techniques for the prediction of microRNA targets. Int. J. Mol. Sci. 2013, 14:8179-8187.
52. Bonev B., et al. MicroRNA-9 reveals regional diversity of neural progenitors along the anterior-posterior axis. Dev. Cell 2011, 20:19-32.
53. Choi W.Y., et al. Target protectors reveal dampening and balancing of Nodal agonist and antagonist by miR-430. Science 2007, 318:271-274.
54. Staton A.A., Giraldez A.J. Use of target protector morpholinos to analyze the physiological roles of specific miRNA-mRNA pairs in vivo. Nat. Protoc. 2011, 6:2035-2049.
55. Knauss J.L., et al. Plasmid-based target protectors allow specific blockade of miRNA silencing activity in mammalian developmental systems. Front. Cell. Neurosci. 2013, 7:163.
56. Wu D., et al. Dicer-microRNA pathway is critical for peripheral nerve regeneration and functional recovery in vivo and regenerative axonogenesis in vitro. Exp. Neurol. 2012, 233:555-565.
57. Willemen H.L., et al. MicroRNA-124 as a novel treatment for persistent hyperalgesia. J. Neuroinflammation 2012, 9:143.
58. Sakai A., et al. miR-7a alleviates the maintenance of neuropathic pain through regulation of neuronal excitability. Brain 2013, 136:2738-2750.
59. He Y., et al. Regulation of opioid tolerance by let-7 family microRNA targeting the mu opioid receptor. J. Neurosci. 2010, 30:10251-10258.
60. Strickland I.T., et al. Axotomy-induced miR-21 promotes axon growth in adult dorsal root ganglion neurons. PLoS ONE 2011, 6:e23423.
61. Sakai A., Suzuki H. Nerve injury-induced upregulation of miR-21 in the primary sensory neurons contributes to neuropathic pain in rats. Biochem. Biophys. Res. Commun. 2013, 435:176-181.
62. Chen H.P., et al. Intrathecal miR-96 inhibits Nav1.3 expression and alleviates neuropathic pain in rat following chronic construction injury. Neurochem. Res. 2013, 39:76-83.
63. Kapranov P., et al. RNA maps reveal new RNA classes and a possible function for pervasive transcription. Science 2007, 316:1484-1488.
64. Spizzo R., et al. Long non-coding RNAs and cancer: a new frontier of translational research?. Oncogene 2012, 31:4577-4587.
65. Ponting C.P., et al. Evolution and functions of long noncoding RNAs. Cell 2009, 136:629-641.
66. Qureshi I.A., Mehler M.F. Long non-coding RNAs: novel targets for nervous system disease diagnosis and therapy. Neurotherapeutics 2013, 10:632-646.
67. Brown C.J., et al. A gene from the region of the human X inactivation centre is expressed exclusively from the inactive X chromosome. Nature 1991, 349:38-44.
68. Derrien T., et al. The GENCODE v7 catalog of human long noncoding RNAs: analysis of their gene structure, evolution, and expression. Genome Res. 2012, 22:1775-1789.
69. Knauss J.L., Sun T. Regulatory mechanisms of long noncoding RNAs in vertebrate central nervous system development and function. Neuroscience 2013, 235:200-214.
70. Faghihi M.A., et al. Expression of a noncoding RNA is elevated in Alzheimer's disease and drives rapid feed-forward regulation of beta-secretase. Nat. Med. 2008, 14:723-730.
71. Korneev S.A., et al. Novel noncoding antisense RNA transcribed from human anti-NOS2A locus is differentially regulated during neuronal differentiation of embryonic stem cells. RNA 2008, 14:2030-2037.
72. Buiting K. Prader-Willi syndrome and Angelman syndrome. Am. J. Med. Genet. C: Semin. Med. Genet. 2010, 154C:365-376.
73. Yu B., et al. Altered long noncoding RNA expressions in dorsal root ganglion after rat sciatic nerve injury. Neurosci. Lett. 2013, 534:117-122.
74. Zhao X., et al. A long noncoding RNA contributes to neuropathic pain by silencing Kcna2 in primary afferent neurons. Nat. Neurosci. 2013, 16:1024-1031.
75. Lee E.J., et al. Identification of piRNAs in the central nervous system. RNA 2011, 17:1090-1099.
76. Rajasethupathy P., et al. A role for neuronal piRNAs in the epigenetic control of memory-related synaptic plasticity. Cell 2012, 149:693-707.
77. Janssen H.L., et al. Treatment of HCV infection by targeting microRNA. N. Engl. J. Med. 2013, 368:1685-1694.
78. Rottiers V., et al. Pharmacological inhibition of a microRNA family in nonhuman primates by a seed-targeting 8-mer antimiR. Sci. Transl. Med. 2013, 5:212ra162.
79. Wu D., et al. MicroRNA machinery responds to peripheral nerve lesion in an injury-regulated pattern. Neuroscience 2011, 190:386-397.
80. Yu B., et al. Altered microRNA expression following sciatic nerve resection in dorsal root ganglia of rats. Acta Biochim. Biophys. Sin. (Shanghai) 2011, 43:909-915.
81. Bali K.K., et al. Sources of individual variability: miRNAs that predispose to neuropathic pain identified using genome-wide sequencing. Mol. Pain 2014, 10:22.
82. Bai G., et al. Downregulation of selective microRNAs in trigeminal ganglion neurons following inflammatory muscle pain. Mol. Pain 2007, 3:15.
83. Ni J., et al. Regulation of mu-opioid type 1 receptors by microRNA134 in dorsal root ganglion neurons following peripheral inflammation. Eur. J. Pain 2013, 17:313-323.
84. Li X., et al. MicroRNA-146a is linked to pain-related pathophysiology of osteoarthritis. Gene 2011, 480:34-41.
85. Li X., et al. Altered spinal microRNA-146a and the microRNA-183 cluster contribute to osteoarthritic pain in knee joints. J. Bone Miner. Res. 2013, 28:2512-2522.
86. Liu N.K., et al. Altered microRNA expression following traumatic spinal cord injury. Exp. Neurol. 2009, 219:424-429.
87. Li H., et al. miR-203 involves in neuropathic pain development and represses Rap1a expression in nerve growth factor differentiated neuronal PC12 cells. Clin. J. Pain. 2014, doi:10.1097/AJP.0000000000000070.
88. Strickland E.R., et al. MicroRNA dysregulation following spinal cord contusion: implications for neural plasticity and repair. Neuroscience 2011, 186:146-160.
89. Nakanishi K., et al. Responses of microRNAs 124a and 223 following spinal cord injury in mice. Spinal Cord 2010, 48:192-196.
90. Bhalala O.G., et al. MicroRNA-21 regulates astrocytic response following spinal cord injury. J. Neurosci. 2012, 32:17935-17947.
91. Arai M., et al. The miRNA and mRNA changes in rat hippocampi after chronic constriction injury. Pain Med. 2013, 14:720-729.
92. Ren K., Dubner R. Interactions between the immune and nervous systems in pain. Nat. Med. 2010, 16:1267-1276.
93. Recchiuti A., et al. MicroRNAs in resolution of acute inflammation: identification of novel resolvin D1-miRNA circuits. FASEB J. 2011, 25:544-560.
94. Yamasaki K., et al. Expression of microRNA-146a in osteoarthritis cartilage. Arthritis Rheum. 2009, 60:1035-1041.
95. Nakasa T., et al. Expression of microRNA-146 in rheumatoid arthritis synovial tissue. Arthritis Rheum. 2008, 58:1284-1292.
96. Taganov K.D., et al. NF-kappaB-dependent induction of microRNA miR-146, an inhibitor targeted to signaling proteins of innate immune responses. Proc. Natl. Acad. Sci. U.S.A. 2006, 103:12481-12486.
97. Monastyrskaya K., et al. miR-199a-5p regulates urothelial permeability and may play a role in bladder pain syndrome. Am. J. Pathol. 2013, 182:431-448.
98. Sanchez Freire V., et al. MicroRNAs may mediate the down-regulation of neurokinin-1 receptor in chronic bladder pain syndrome. Am. J. Pathol. 2010, 176:288-303.
99. Orlova I.A., et al. MicroRNA modulation in complex regional pain syndrome. J. Transl. Med. 2011, 9:195.
100. Sun Y., et al. miR-203 regulates nociceptive sensitization after incision by controlling phospholipase A2 activating protein expression. Anesthesiology 2012, 117:626-638.
101. Kino T., et al. Noncoding RNA gas5 is a growth arrest- and starvation-associated repressor of the glucocorticoid receptor. Sci. Signal. 2010, 3:ra8.
102. Ng S.Y., et al. Human long non-coding RNAs promote pluripotency and neuronal differentiation by association with chromatin modifiers and transcription factors. EMBO J. 2012, 31:522-533.
103. Cesana M., et al. A long noncoding RNA controls muscle differentiation by functioning as a competing endogenous RNA. Cell 2011, 147:358-369.
104. Karreth F.A., et al. In vivo identification of tumor-suppressive PTEN ceRNAs in an oncogenic BRAF-induced mouse model of melanoma. Cell 2011, 147:382-395.
105. Salmena L., et al. A ceRNA hypothesis: the Rosetta Stone of a hidden RNA language?. Cell 2011, 146:353-358.
106. Tsai M.C., et al. Long noncoding RNA as modular scaffold of histone modification complexes. Science 2010, 329:689-693.
107. Gong C., Maquat L.E. lncRNAs transactivate STAU1-mediated mRNA decay by duplexing with 3' UTRs via Alu elements. Nature 2011, 470:284-288.
108. Tripathi V., et al. The nuclear-retained noncoding RNA MALAT1 regulates alternative splicing by modulating SR splicing factor phosphorylation. Mol. Cell 2010, 39:925-938.
109. Yoon J.H., et al. LincRNA-p21 suppresses target mRNA translation. Mol. Cell 2012, 47:648-655.